铁调素与早产儿缺铁性贫血的研究现状

doi:10.3877/cma.j.issn.1673-5250.2021.02.001

缺铁性贫血(IDA)是早产儿生后面临的最主要挑战之一。IDA严重影响早产儿的体格生长、免疫功能及神经系统发育。目前，尚无早期诊断早产儿IDA的特异性指标，并且对于早产儿IDA亦缺乏统一诊断和治疗标准。对于铁调素测定，可以早期特异性反映早产儿体内铁状态变化，并且可用于早期诊断早产儿IDA，而且敏感度及特异度均较高，还可为临床制定早产儿IDA更精准诊疗方案提供依据。但是，对于铁调素与早产儿铁代谢的关系及其在早产儿IDA诊疗中的价值，迄今相关研究尚甚少。笔者拟就铁调素的作用机制、孕妇铁代谢对早产儿铁调素的影响、铁调素对早产儿IDA诊治意义及铁调素与铁过载的关系，对铁调素与早产儿IDA的最新研究进展进行阐述。

关键词: 贫血, 缺铁性, 血红蛋白类, 铁调素, 铁代谢障碍, 铁超负荷, 促红细胞生成素, 婴儿, 早产

Iron deficiency anemia (IDA) is one of the most important challenges for premature infants, which seriously affects their physical growth, immune function and nervous system development. There is no unified international standard for diagnosis and treatment of premature infants with IDA, as well as the lack of specific indicators for early diagnosis of IDA in premature infants. At present, results of studies have shown that hepcidin detection can specifically reflect changes of iron status in preterm infants at an early stage, and can be used for early diagnosis of IDA in preterm infants with high sensitivity and specificity. It can also provide reference for clinical development of more accurate diagnosis and treatment programs for preterm infants with IDA. However, there are few relevant studies about relationship between hepcidin and iron metabolism in preterm infants and its value in diagnosis and treatment of IDA in preterm infants. This review intends to elaborate on the latest progresses of relationships between hepcidin and IDA in premature infants from aspects of mechanism of hepcidin, effect of iron metabolism in pregnant women on hepcidin of premature infants, significance of hepcidin in diagnosis and treatment of premature infants with IDA, and relationship between hepcidin and iron overload.

Key words: Anemia, iron-deficiency, Hemoglobins, Hepcidin, Iron metabolism disorders, Iron overload, Erythropoietin, Infant, premature

图1 影响铁调素表达的主要因素

[1]	Camaschella C. New insights into iron deficiency and iron deficiency anemia[J]. Blood Rev, 2017, 31(4): 225-233. DOI: 10.1093/hmg/ddv061.
[2]	Muleviciene A, Sestel N, Stankeviciene S, et al. Assessment of risk factors for iron deficiency anemia in infants and young children: a case-control study[J]. Breastfeed Med, 2018, 13(7): 493-499. DOI: 10.1089/bfm.2018.0083.
[3]	Ferri C, Procianoy RS, Silveira RC. Prevalence and risk factors for iron-deficiency anemia in very-low-birth-weight preterm infants at 1 year of corrected age[J]. J Trop Pediatr, 2014, 60(1): 53-60. DOI: 10.1093/tropej/fmt077.
[4]	Akkermans MD, Uijterschout L, Abbink M, et al. Predictive factors of iron depletion in late preterm infants at the postnatal age of 6 weeks[J]. Eur J Clin Nutr, 2016, 70(1): 941-946. DOI: 10.1038/ejcn.2016.34.
[5]	Suwannakeeree P, Jangmeonwai P. The prevalence and risk factors of iron deficiency anemia in Thai infants by complete blood count at 9-month-old[J]. J Med Assoc Thai, 2020, 10(9): 891-896. DOI: 10.35755/jmedassocthai.2020.09.10904.
[6]	Fernandez MJ, Ochoa JJ, Dada GOL, et al. Iron deficiency and iron homeostasis in low birth weight preterm infants: a systematic review[J]. Nutrients, 2019, 11(5): 1090-2010. DOI: 10.3390/nu11051090.
[7]	Georgieff MK. Iron assessment to protect the developing brain[J]. Am J Clin Nutr, 2017, 106(6): 1593-1588. DOI: 10.3945/ajcn.117.155846.
[8]	Algarin C, Karunakaran KD, Reyes S, et al. Differences on brain connectivity in adulthood are present in subjects with iron deficiency anemia in infancy[J]. Front Aging Neurosci, 2017, 9: 54. DOI: 10.3389/fnagi.2017.00054.
[9]	Pagani A, Nai A, Silvestri L, et al. Hepcidin and anemia: a tight relationship[J]. Front Physiol, 2019, 10: 1294. DOI: 10.3389/fphys.2019.01294.
[10]	Berglund SK, Chmielewska AM, Domellf M, et al. Hepcidin is a relevant iron status indicator in infancy: results from a randomized trial of early vs. delayed cord clamping[J]. Pediatr Res, 2020, 59: 101318. DOI: 10.1038/s41390-020-1045-9.
[11]	Korlesky C, Kling PJ, Pham DQP, et al. Cord blood erythropoietin and hepcidin reflect lower newborn iron stores due to maternal obesity during pregnancy[J]. Am J Perinatol, 2018, 36(5): 511-516. DOI: 10.1055/s-0038-1669444.
[12]	Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era[J]. Haematologica, 2020，105(2): 260-272. DOI: 10.3324/haematol.2019.232124.
[13]	Chappell M, Rivella S. New potential players in hepcidin regulation[J]. Haematologica, 2019, 104(9): 1691-1693. DOI: 10.3324/haematol.2019.224311.
[14]	Lesbordes-Brion JC, Viatte L, Bennoun M, et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis[J]. Blood, 2006, 108(4): 1402-1405. DOI: 10.1182/blood-2006-02-003376.
[15]	Roy CN, Mak HH, Akpan I, et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation[J]. Blood, 2007, 109(9): 4038-4044. DOI: 10.1182/blood-2006-10-051755.
[16]	Roth MP, Meynard D, Coppin H. Regulators of hepcidin expression[J]. Vitam Horm, 2019, 110: 101-129. DOI: 10.1016/bs.vh.2019.01.005.
[17]	Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin[J]. Adv Nutr, 2017, 8(1): 126-136. DOI: 10.3945/an.116.013961.
[18]	Arezes J, Foy N, Mchugh K, et al. Erythroferrone inhibits the induction of hepcidin by BMP6[J]. Blood, 2018, 132(14): 1473-1477. DOI: 10.1182/blood-2018-06-857995.
[19]	Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator[J]. Biosci Rep, 2015, 35(3): e00192. DOI: 10.1042/BSR20150014.
[20]	Ganz T. Erythropoietic regulators of iron metabolism[J]. Free Radic Biol Med, 2019, 133: 69-74. DOI: 10.1016/j.freeradbiomed.2018.07.003.
[21]	Harigae H. Iron metabolism and the related diseases[J]. Int J Hematol, 2018, 107(1): 5-6. DOI: 10.1007/s12185-017-2384-0.
[22]	Ru Y, Pressman EK, Guillet R, et al. Umbilical cord hepcidin concentrations are positively associated with the variance in iron status among multiple birth neonates[J]. J Nutr, 2018, 148(2): 1716-1722. DOI: 10.1093/jn/nxy151.
[23]	Bencaiova GA, Vogt DR, Hoesli I. Serum hepcidin and iron status parameters in pregnant women and the association with adverse maternal and fetal outcomes: a study protocol for a prospective cohort study[J]. BMJ Open, 69(11): e032280. DOI: 10.1136/bmjopen-2019-032280.
[24]	Basu S, Kumar N, Srivastava R, et al. Maternal and cord blood hepcidin concentrations in severe iron deficiency anemia[J]. Pediatr Neonatol, 2016, 57(5): 413-419. DOI: 10.1016/j.pedneo.2015.09.012.
[25]	Kim HA, Park SH, Lee EJ. Iron status in small for gestational age and appropriate for gestational age infants at birth[J]. Korean J Pediatr, 2018, 62(3): 102-107. DOI: 10.3345/kjp.2018.06653.
[26]	Rehu M, Punnonen K, Ostland V, et al. Maternal serum hepcidin is low at term and independent of cord blood iron status[J]. Eur J Haematol, 2010, 85(4): 345-352. DOI: 10.1111/j.1600-0609.2010.01479.x.
[27]	Cross JH, Prentice AM, Carla C. Hepcidin, serum iron and transferrin saturation in full term and premature infants during the first month of life: a state-of-the-art review of existing evidence in humans[J]. Curr Dev Nutr, 2020, 4(8): nzaa104. DOI: 10.1093/cdn/nzaa104.
[28]	Ichinomiya K, Maruyama K, Inoue T, et al. Perinatal factors affecting serum hepcidin levels in low-birth-weight infants[J]. Neonatology, 2017, 112(2): 110-116. DOI: 10.1159/000473871.
[29]	Stinson LF, Payne MS. Infection-mediated preterm birth: bacterial origins and avenues for intervention[J]. Aust N Z J Obstet Gynaecol, 2019, 59(6): 781-790. DOI: 10.1111/ajo.13078.
[30]	Armitage AE, Agbla SC, Betts M, et al. Rapid growth is a dominant predictor of hepcidin suppression and declining ferritin in Gambian infants[J]. Haematologica, 2019, 104(8): 1542-1553. DOI: 10.3324/haematol.2018.210146.
[31]	Pasricha SR, Atkinson SH, Armitage AE, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children[J]. Sci Transl Med, 2014, 6(235): 235re3. DOI: 10.1126/scitranslmed.3008249.
[32]	Albaroudi IN, Khodder M, Al Saadi T, et al. Prevalence, diagnosis, and management of iron deficiency and iron deficiency anemia among Syrian children in a major outpatient center in Damascus, Syria[J]. Avicenna J Med, 2018, 8(3): 92-103. DOI: 10.4103/ajm.AJM_169_17.
[33]	Babaei M, Shafiei S, Bijani A, et al. Ability of serum ferritin to diagnose iron deficiency anemia in an elderly cohort[J]. Rev Bras Hematol Hemoter, 2017, 39(3): 223-228. DOI: 10.1016/j.bjhh.2017.02.002.
[34]	Uijterschout L, Domellof M, Berglund S, et al. Serum hepcidin in infants born after 32 to 37 wk of gestational age[J]. Pediatr Res, 2016, 79(4): 608-613. DOI: 10.1038/pr.2015.258.
[35]	Müller KF, Lorenz L, Poets CF, et al. Hepcidin concentrations in serum and urine correlate with iron homeostasis in preterm infants[J]. J Pediatr, 2012, 160(6): 949-953. DOI: 10.1016/j.jpeds.2011.12.030.
[36]	Dewan P, Dixit A, Gomber S, et al. Serum and urinary hepcidin for diagnosing iron-deficiency anemia in under-5 children[J]. J Pediatr Hematol Oncol, 2018, 41(4): 216-220. DOI: 10.1097/MPH.0000000000001320.
[37]	Berglund S, Lonnerdal B, Westrup B, et al. Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants[J]. Am J Clin Nutr, 2011, 94(6): 1553-1561. DOI: 10.3945/ajcn.111.013938.
[38]	Bregman DB, Morris D, Koch TA, et al. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia[J]. Am J Hematol, 2013, 88(2): 97-101. DOI: 10.1182/blood.V120.21.484.484.
[39]	Brannon PM, Taylor CL. Iron supplementation during pregnancy and infancy: uncertainties and implications for research and policy[J]. Nutrients, 2017, 9(12): 1327. DOI: 10.3390/nu9121327.
[40]	Najeeb T, Anjum N. Association of cord hepcidin and iron parameters with maternal hepcidin, iron status markers and neonatal morphometrics[J]. Pak J Physiol, 2018, 14(2): 7-10.
[41]	Frazer DM, Wilkins SJ, Darshan D, et al. Ferroportin is essential for iron absorption during suckling, but is hyporesponsive to the regulatory hormone hepcidin[J]. Cell Mol Gastroenterol Hepatol, 2016, 3(3): 410-421. DOI: 10.1016/j.jcmgh.2016.12.002.
[42]	Raffaeli G, Manzoni F, Cortesi V, et al. Iron homeostasis disruption and oxidative stress in preterm newborns[J]. Nutrients, 2020, 12(6): 1554. DOI: 10.3390/nu12061554.
[43]	Treviño-Báez JD, Briones-Lara E, Alamillo-Velázquez J, et al. Multiple red blood cell transfusions and iron overload in very low birthweight infants[J]. Vox Sanguinis, 2017, 112(5): 453-458. DOI: 10.1111/vox.12528.
[44]	Lönnerdal B. Excess iron intake as a factor in growth, infections, and development of infants and young children[J]. Am J Clin Nutr, 2017, 106(6): 1681-1687. DOI: 10.3945/ajcn.117.156042.
[45]	Hare DJ, Cardoso BR, Raven EP, et al. Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson′s disease[J]. NPJ Parkinsons Dis, 2017, 3(1): 1-5. DOI: 10.1038/s41531-016-0004-y.
[46]	Wessling-Resnick M. Excess iron: considerations related to development and early growth[J]. Am J Clin Nutr, 2017, 106(6): 1600-1605. DOI: 10.3945/ajcn.117.155879.
[47]	Szudzik M, Starzyński RR, Jończy A, et al. Iron supplementation in suckling piglets: an ostensibly easy therapy of neonatal iron deficiency anemia[J]. Pharmaceuticals, 2018, 11(4): 128. DOI: 10.3390/ph11040128.
[48]	《中华儿科杂志》编辑委员会. 儿童缺铁和缺铁性贫血防治建议[J]. 中国儿童保健杂志，2010, 46(8): 502-504. DOI: 10.3321/j.issn:0578-1310.2008.07.006.

[1]	杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[2]	董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[3]	周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[4]	魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[5]	胡诤贇, 史建伟, 申建伟, 王冰, 蒋春苗, 刘冲. 基于机器学习鉴定早产儿支气管肺发育不良的关键基因[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 446-454.
[6]	杨莹, 刘艳, 王央丹. 新生儿结节性硬化症相关性癫痫1例并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 464-472.
[7]	周美岑, 王华, 母得志. 早产儿疫苗预防接种及时性[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 261-266.
[8]	李敏, 熊菲. 母乳成分及其影响因素的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 267-272.
[9]	赵金琦, 杨楠, 宫丽霏, 唐玥, 李璐璐, 杨海河, 孔元原. 2011—2020年北京市小于胎龄儿出生状况分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 278-286.
[10]	李聪, 徐艳, 吴铭, 丁瑞东, 王军. 极低出生体重儿出生时血清25-羟维生素D水平与其生后早期喂养不耐受关系的临床分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 309-314.
[11]	高静, 严学倩, 及月茹, 郝淼旺, 刘苍春. 胃癌患者以慢性贫血为首发表现的高危因素Logistic分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 534-537.
[12]	李君, 范铁艳, 牛鑫鑫, 陈虹. 肝移植后他克莫司致缺铁性贫血一例[J]. 中华移植杂志(电子版), 2023, 17(03): 169-170.
[13]	李芸芸, 吴涛, 毛东锋, 鱼玲玲, 刘文慧. 轻型β-地中海贫血供者异基因造血干细胞移植治疗重型再生障碍性贫血1例[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 84-86.
[14]	樊佩琦, 闫燕, 李晓霞, 武玲宇, 郭罡玲, 李静, 王利华. 2020年山西省腹膜透析患者贫血的流行病学调查及相关因素分析[J]. 中华肾病研究电子杂志, 2023, 12(03): 121-126.
[15]	张丹, 颜新生, 张李涛, 张真路, 王栋. 利用质量工具减少地中海贫血基因检测复查率[J]. 中华临床实验室管理电子杂志, 2023, 11(02): 79-83.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Hepcidin and premature infants with iron deficiency anemia: a comprehensive review

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Hepcidin and premature infants with iron deficiency anemia: a comprehensive review